Characterization of a novel CUB domain containing protein with immune functions in Mytilus galloprovincialis.

Fish Shellfish Immunol

Laboratory of Marine Biology Protein Engineering, Marine Science and Technical College, Zhejiang Ocean University, Zhoushan City 316022, Zhejiang, China. Electronic address:

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

CUB (Complement/Uegf/Bmp) domain is a structural motif present in many proteins with important functions in tissue development and immunity. CUB-domain-containing proteins (CDCPs) have been identified as immune-related molecules from bivalves. However, the knowledge about the role of CDCP in bivalves' immunity is still limited. In this study, a novel CDCP containing a signal peptide and only one CUB domain was characterized from Mytilus galloprovincialis and named Mg-CUB here. The tissue distribution and expression profiles of Mg-CUB gene after microbes' stimulation were determined. In addition, Mg-CUB was recombinantly expressed and the immune-related functions of rMg-CUB protein were tested. Mg-CUB exhibits a wide distribution in all tested tissues with the highest expression level was observed in adductor muscle followed by hemocytes. Infection with bacteria significantly up-regulated the expression level of Mg-CUB in the hemocytes, suggesting that Mg-CUB might be involved in host immune defense response. Recombinant Mg-CUB (rMg-CUB) exhibited relatively stronger antimicrobial activity against Gram-negative bacteria, as well as binding capacity and agglutination ability for the tested bacteria. In addition, rMg-CUB also showed binding ability with lipopolysaccharide and peptidoglycan. Injection of rMg-CUB protein significantly increased the expression level of TLR4, MyD88, and NF-κB in the hemocytes, indicating a potential role of Mg-CUB in the activation of the related signaling pathway. This study provided valuable data for understanding the biological roles of CUB domain as both immune effector and pattern recognition receptor (PRR) in the innate immune system of mollusks.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fsi.2025.110334DOI Listing

Publication Analysis

Top Keywords

cub domain
12
expression level
12
mytilus galloprovincialis
8
mg-cub
8
rmg-cub protein
8
characterization novel
4
cub
4
novel cub
4
domain
4
domain protein
4

Similar Publications

Although the potential causal associations between cell-derived signaling molecules and sleep disorder (SD) have been reported, contradictions remain. This study assessed the causal effects and the mediating role of 1400 metabolites among 91 cell-derived signaling molecules and SD from a genetic perspective by performing Mendelian randomization (MR) analyses. Genetic instruments derived from publicly available genome-wide association studies were employed in this study, including 49,880 SD cases and 358,194 controls.

View Article and Find Full Text PDF

Background: Triple-negative type of breast cancer (TNBC) has limited therapeutic options and frequently metastasizes, leading to low survival rates. Oxidative phosphorylation (OXPHOS) is a driver of TNBC metastasis, but the signaling underlying this metabolic change is poorly understood.

Methods: We performed metabolic assays and assessed migratory and metastatic potential in cells with manipulated CDCP1/mitochondrial Src signaling.

View Article and Find Full Text PDF

Gemcitabine is commonly used in the standard first-line treatment of urothelial carcinoma (UC); however, the emergence of drug resistance significantly limits its clinical benefit. The present study aims to investigate the role of CUB domain-containing protein 1 (CDCP1) in mediating resistance to gemcitabine in UC cells. Gemcitabine-resistant T24 (T24-GR) cells exhibited downregulation of human equilibrative nucleoside transporter 1 and upregulation of cytidine deaminase, key regulators of gemcitabine metabolism, as well as increased CDCP1 expression.

View Article and Find Full Text PDF

Discoidin, CUB and LCCL domain containing 2 modulates angiogenesis by inhibiting VEGF receptor 2 endocytosis in endothelial cells.

J Mol Med (Berl)

September 2025

Department of Biochemistry and Molecular Biology, School of Basic Medicine, Hebei Medical University, Shijiazhuang, Hebei Province, China, 050017.

The internalization of vascular endothelial growth factor receptor-2 (VEGFR-2) occurs in response to VEGF treatment, and it is eventually transported to the plasma membrane by several endosomes such as Rab5 and Rab11, which are responsible for transporting vesicles from the cytoplasm to plasma membrane. Therefore, the homeostasis of VEGFR-2 internalization and recycling is critical for maintaining the normality of the VEGF signaling pathway and regulates angiogenesis. Previous studies have shown that discoidin, CUB and LCCL domain containing 2 (DCBLD2) can promote the proliferation and migration of vascular endothelial cells (ECs) by promoting the VEGF signaling pathway, but the potential role of DCBLD2 on VEGFR-2 endocytosis remains unclear.

View Article and Find Full Text PDF

CDCP1-targeting ADC outperforms standard therapies in Ras-mutant pancreatic cancer.

Mol Ther Oncol

September 2025

College of Pharmacy, Ajou University, 206 World Cup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do 16499, Republic of Korea.

mutations are found in 10%-30% of various cancers and in up to 90% of pancreatic cancers, where they are associated with aggressive phenotypes, poor prognosis, and reduced overall survival. CUB domain containing protein 1 (CDCP1), a transcriptional target of activated RAS, is implicated in these cancers irrespective of the specific mutation. Given the limited effectiveness of small-molecule inhibitors against mutant Ras-driven cancers, we developed a CDCP1-targeting antibody-drug conjugate (ADC).

View Article and Find Full Text PDF